Gait Disorders, Neurologic — Dynamic Gait Index in Children With Dyslexia
Citation(s)
Barela JA, Dias JL, Godoi D, Viana AR, de Freitas PB Postural control and automaticity in dyslexic children: the relationship between visual information and body sway. Res Dev Disabil. 2011 Sep-Oct;32(5):1814-21. doi: 10.1016/j.ridd.2011.03.011. Epub 201
Cattaneo D, Jonsdottir J, Repetti S Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil. 2007 Dec 30;29(24):1920-5. doi: 10.1080/09638280701191859. Epub 2007 Apr 26.
de Freitas PB, Pedao ST, Barela JA Visuomotor processing and hand force coordination in dyslexic children during a visually guided manipulation task. Res Dev Disabil. 2014 Oct;35(10):2352-8. doi: 10.1016/j.ridd.2014.06.002. Epub 2014 Jun 22.
Gouleme N, Gerard CL, Bucci MP The Effect of Training on Postural Control in Dyslexic Children. PLoS One. 2015 Jul 10;10(7):e0130196. doi: 10.1371/journal.pone.0130196. eCollection 2015.
Kapoula Z, Bucci MP Postural control in dyslexic and non-dyslexic children. J Neurol. 2007 Sep;254(9):1174-83. doi: 10.1007/s00415-006-0460-0. Epub 2007 Aug 3.
Reliability of the Dynamic Gait Index in Children With Dyslexia
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
